Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infection

Autor: L. Brock Thornton, Daniel C. Whitehead, Kerrick C. Rees, Melanie Key, Amy Bergmann, Zhicheng Dou, Iqbal Hamza, Carly Dameron, Katherine Floyd
Rok vydání: 2020
Předmět:
Protozoan Proteins
Artificial Gene Amplification and Extension
Biochemistry
Polymerase Chain Reaction
Toxoplasma Gondii
chemistry.chemical_compound
Medicine and Health Sciences
Biology (General)
Post-Translational Modification
Heme
Phylogeny
Plant Proteins
Protozoans
0303 health sciences
biology
030302 biochemistry & molecular biology
Eukaryota
Plants
Protoporphyrinogen oxidase
Toxoplasma
Toxoplasmosis
Intracellular
Research Article
QH301-705.5
Immunology
Biosynthesis
Research and Analysis Methods
Microbiology
Parasite Replication
Cofactor
03 medical and health sciences
Virology
parasitic diseases
Organelle
Parasitic Diseases
Genetics
Humans
Protoporphyrinogen Oxidase
Molecular Biology Techniques
Molecular Biology
030304 developmental biology
Apicoplast
Host Cells
Organisms
Biology and Life Sciences
Proteins
Toxoplasma gondii
RC581-607
biology.organism_classification
Parasitic Protozoans
chemistry
biology.protein
Parasitology
Immunologic diseases. Allergy
Viral Transmission and Infection
Zdroj: PLoS Pathogens
PLoS Pathogens, Vol 16, Iss 5, p e1008499 (2020)
ISSN: 1553-7374
Popis: Heme, an iron-containing organic ring, is essential for virtually all living organisms by serving as a prosthetic group in proteins that function in diverse cellular activities ranging from diatomic gas transport and sensing, to mitochondrial respiration, to detoxification. Cellular heme levels in microbial pathogens can be a composite of endogenous de novo synthesis or exogenous uptake of heme or heme synthesis intermediates. Intracellular pathogenic microbes switch routes for heme supply when heme availability fluctuates in their replicative environment throughout infection. Here, we show that Toxoplasma gondii, an obligate intracellular human pathogen, encodes a functional heme biosynthesis pathway. A chloroplast-derived organelle, termed apicoplast, is involved in heme production. Genetic and chemical manipulation revealed that de novo heme production is essential for T. gondii intracellular growth and pathogenesis. Surprisingly, the herbicide oxadiazon significantly impaired Toxoplasma growth, consistent with phylogenetic analyses that show T. gondii protoporphyrinogen oxidase is more closely related to plants than mammals. This inhibition can be enhanced by 15- to 25-fold with two oxadiazon derivatives, lending therapeutic proof that Toxoplasma heme biosynthesis is a druggable target. As T. gondii has been used to model other apicomplexan parasites, our study underscores the utility of targeting heme biosynthesis in other pathogenic apicomplexans, such as Plasmodium spp., Cystoisospora, Eimeria, Neospora, and Sarcocystis.
Author summary Toxoplasma gondii infects essentially all warm-blooded animals due to its broad species and tissue tropism. Almost one-third of the human population carry Toxoplasma infection, which can cause severe morbidity and mortality in immunocompromised individuals. The current antibiotics against Toxoplasma trigger strong side effects in some groups of patients and have limited efficacy on congenital toxoplasmosis. Thus, an urgent need for novel therapeutics exist. Here, we show that Toxoplasma gondii actively produces heme, a key nutrient for many subcellular activities, via its plant-like heme biosynthesis pathway for intracellular growth and acute virulence. We found that several herbicidal heme biosynthesis inhibitors and their derivatives show inhibitory effects against intracellular Toxoplasma growth. Our findings provide evidence that disrupting heme production in Toxoplasma could be an effective therapeutic strategy to control infection.
Databáze: OpenAIRE